The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Enobosarm: A targeted therapy for metastatic, androgen receptor positive, breast cancer.
Beth Overmoyer
Research Funding - GTx
Pedro Sanz-Altamira
Research Funding - GTx
Ryan P. Taylor
Employment or Leadership Position - GTx
Michael L. Hancock
Employment or Leadership Position - GTx
James T. Dalton
Employment or Leadership Position - GTx
Mary Ann Johnston
Employment or Leadership Position - GTx
Mitchell S. Steiner
Employment or Leadership Position - GTx
Stock Ownership - GTx (B)